Several other equities research analysts also recently weighed in on the company. SunTrust Banks reaffirmed a buy rating and set a $46.00 price target on shares of Olin in a report on Monday, November 6th. TheStreet raised Olin from a c+ rating to a b rating in a report on Tuesday, October 31st. Cowen reaffirmed an outperform rating and set a $42.00 price target (up from $39.00) on shares of Olin in a report on Tuesday, October 10th. Zacks Investment Research raised Olin from a sell rating to a hold rating in a report on Tuesday, October 17th. Finally, Royal Bank of Canada reaffirmed a buy rating and set a $42.00 price target on shares of Olin in a report on Thursday, December 14th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company has an average rating of Buy and an average target price of $39.10.
Shares of Olin (NYSE OLN) traded up $0.64 during trading on Wednesday, reaching $37.95. 1,788,300 shares of the company’s stock traded hands, compared to its average volume of 1,932,963. The stock has a market capitalization of $6,320.00, a price-to-earnings ratio of 82.50, a P/E/G ratio of 1.20 and a beta of 1.39. Olin has a one year low of $25.60 and a one year high of $38.84. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.72 and a quick ratio of 1.03.
Olin (NYSE:OLN) last announced its quarterly earnings results on Monday, October 30th. The specialty chemicals company reported $0.31 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.35 by ($0.04). The company had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Olin had a net margin of 1.29% and a return on equity of 6.05%. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.11 earnings per share. sell-side analysts predict that Olin will post 0.93 earnings per share for the current year.
In related news, VP Dolores J. Ennico sold 15,000 shares of Olin stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $36.80, for a total transaction of $552,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP John L. Mcintosh sold 9,500 shares of Olin stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $35.42, for a total value of $336,490.00. The disclosure for this sale can be found here. In the last three months, insiders sold 75,083 shares of company stock valued at $2,741,284. 2.90% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Olin by 9.7% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,126 shares of the specialty chemicals company’s stock worth $185,000 after purchasing an additional 544 shares in the last quarter. Comerica Securities Inc. grew its holdings in Olin by 0.6% in the 2nd quarter. Comerica Securities Inc. now owns 99,523 shares of the specialty chemicals company’s stock valued at $3,014,000 after buying an additional 561 shares during the period. PNC Financial Services Group Inc. grew its holdings in Olin by 2.1% in the 2nd quarter. PNC Financial Services Group Inc. now owns 61,507 shares of the specialty chemicals company’s stock valued at $1,863,000 after buying an additional 1,242 shares during the period. Advisor Group Inc. grew its holdings in Olin by 7.4% in the 2nd quarter. Advisor Group Inc. now owns 21,171 shares of the specialty chemicals company’s stock valued at $641,000 after buying an additional 1,465 shares during the period. Finally, Financial Engines Advisors L.L.C. grew its holdings in Olin by 2.5% in the 3rd quarter. Financial Engines Advisors L.L.C. now owns 68,528 shares of the specialty chemicals company’s stock valued at $2,347,000 after buying an additional 1,696 shares during the period. Hedge funds and other institutional investors own 89.68% of the company’s stock.
WARNING: This report was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://ledgergazette.com/2018/01/12/vertical-research-upgrades-olin-oln-to-buy.html.
Olin Company Profile
Olin Corporation is a manufacturer and distributor of chemical products, and ammunition. The Company operates through three segments: Chlor Alkali Products and Vinyls, Epoxy and Winchester. The Chlor Alkali Products and Vinyls segment manufactures and sells chlorine and caustic soda, ethylene dichloride and vinyl chloride monomer, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products and potassium hydroxide.
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.